companydata.dkcompanydata.dk

OLANDER CLINICAL CONSULTING K/S: Financial statements 2020

CVR: 35860177

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,535,704 and a net result of DKK 1,501,968 compared with DKK 1,407,595 the year before. That is an increase of 6.9% compared with the year before. Equity in the 2020 report amounted to DKK 461,017. The solvency ratio was 49.2%.

Gross Profit
DKK 1,535,704
Profit/Loss
DKK 1,501,968
Equity
DKK 461,017
Total Assets
DKK 937,566

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-1.5M1.5M461K-
2019-1.4M1.4M491K-
2018-1.7M1.7M700K-
2017-1.3M1.3M518K-
2016-1.5M1.5M699K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is OLANDER CLINICAL CONSULTING K/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

OLANDER CLINICAL CONSULTING K/S: The 2019 annual report is outAug 20, 2020

OLANDER CLINICAL CONSULTING K/S has published its annual report for 2019. Gross profit came to DKK 1,436,888, and the net result was DKK 1,407,595.

About OLANDER CLINICAL CONSULTING K/S

OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity in the 2025 report amounted to DKK 303,261.

Source: annual report 2025, Danish Business Authority